Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Dec;3(12):1552–1564. doi: 10.1158/1940-6207.CAPR-10-0047

Table 1.

Characteristics of subjects in the methylation analysis

Characteristic Individuals included in the methylation analysis (n=388) Individuals included in the entire study (n = 1121)
Age, mean (SD), y 57.8 (9.1) 57.5 (9.6)
Male—no. (%). 246 (63.4) 712 (63.5)
Smoker—no. (%) 58 (15.0) 164 (14.5)
Alcohol drinker — no. (%) 123 (33.0) 340 (31.5)
Treatment
 Placebo 123 (31.7) 372 (33.2)
 Aspirin 80mg/d 137 (35.3) 377 (33.6)
 Aspirin 325 mg/d 128 (33.0) 372 (33.2)
Treatment
 Placebo 190 (49.0) 505 (49.5)
 Folate 1 mg/d 198 (51.0) 516 (50.5)
Race or ethnic group--no. (%)
 White 325 (83.8) 958 (85.5)
 African American 22 (5.7) 68 (6.1)
 Hispanic 22 (5.7) 61 (5.4)
 Other 19 (4.9) 34 (3.0)
BMI, mean (SD) 27.3 (4.6) 27.4 (4.5)
Baseline plasma folate, mean ± (SD), (nmol/l) 20.9 (15.4) 23.3 (15.6)
Year three plasma folate, mean ± (SD), (nmol/l) 53.4 (36.5) 50.6 (34.7)
Baseline RBC folate, mean ± (SD), (ng/ml) 396.4 (141.5) 407.9 (152.9)
Year three RBC folate, mean ± (SD), (ng/ml) 809.3 (345.5) 836.8 (303.5)
Dietary intake
 Total calories, mean ± (SD), (kcal/d) 1601.4 (624.8) 1634 (667.0)
 Carbohydrates, mean ± (SD), g per day 180.3 (72.4) 185.9 (77.4)
 Fat—total, mean ± (SD), g/d 63.7 (32.6) 65.1 (34.3)
 Fiber, mean ± (SD), g/d 12.8 (5.9) 13.3 (6.0)
 Folate, mean ± (SD), μg/d 305.0 (7.7) 319.9 (156.6)
 Protein, mean ± (SD), g/d, g/d 64.2 (25.2) 65.4 (27.1)